RIPK4 and melanoma: These are manifested by less pronounced effects of RIPK4 silencing on morphology and expression of pro-invasive markers in A375 cells than in WM266.4 cells, and by differential effects of PKC on RIPK4/NF-κB axis and the invasive potential of melanoma cell lines.